- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
SOX17 expression in ovarian clear cell carcinoma ; volume:17 ; number:1 ; day:11 ; month:11 ; year:2024 ; pages:1-9 ; date:12.2024
Journal of ovarian research ; 17, Heft 1 (11.11.2024), 1-9, 12.2024
- Creator
-
Kodama, Daichi
Takenaka, Motoki
Saigo, Chiemi
Azuma, Masako
Hanamatsu, Yuki
Isobe, Masanori
Takeuchi, Tamotsu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-024-01549-3
- URN
-
urn:nbn:de:101:1-2501282130559.113567883621
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kodama, Daichi
- Takenaka, Motoki
- Saigo, Chiemi
- Azuma, Masako
- Hanamatsu, Yuki
- Isobe, Masanori
- Takeuchi, Tamotsu
- SpringerLink (Online service)
Other Objects (12)
Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
PD-L1 expression in ovarian clear cell carcinoma using the 22C3 pharmDx assay
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
Napsin A as a marker of clear cell ovarian carcinoma
A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma
Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1)
Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions
Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
PD-L1 expression in ovarian clear cell carcinoma using the 22C3 pharmDx assay
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
Napsin A as a marker of clear cell ovarian carcinoma
A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma
Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1)
Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions
Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
PD-L1 expression in ovarian clear cell carcinoma using the 22C3 pharmDx assay
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
Napsin A as a marker of clear cell ovarian carcinoma
A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma
Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1)
Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR